Appetite suppression: Difference between revisions
>Josikins revisiting effect overhauls and proofreading/adding minor tweaks |
>Josikins revisiting effect overhauls and proofreading/adding minor tweaks |
(No difference)
| |
Revision as of 19:22, 10 March 2018
Appetite suppression can be described as the experience of a distinct decrease in a person's sense of hunger and appetite. This results in both a lesser desire to eat food and a decreased enjoyment of its taste. This typically results in the person undergoing prolonged periods of time without eating food.
Depending on the intensity, this effect can result in a sense of complete disinterest or even disgust concerning food. At times, it can often result in physical discomfort (such as Nausea) when attempting to eat food. In cases of severe appetite suppression, it is often easier for one to consume liquid food, such as protein shakes, in order to receive the nutrition needed to function.
Appetite suppression is often accompanied by other coinciding effects such as stimulation or pain relief in a manner which can lead to feeling as if one either has enough energy to not need food or has enough anaesthesthia to not feel the pain of hunger. It is most commonly induced under the influence of moderate dosages of stimulant compounds, such as amphetamine, methylphenidate, nicotine, MDMA, and cocaine. However, it may also occur under the influence of other compounds such as opioids, psychedelics, and selective serotonin reuptake inhibitors (SSRIs). It is worth noting that if these substances are used for prolonged periods of time, weight loss often occurs as a result.
Psychoactive substances
Compounds within our psychoactive substance index which may cause this effect include:
- 1B-LSD
- 1P-LSD
- 1V-LSD
- 1cP-AL-LAD
- 1cP-LSD
- 1cP-MiPLA
- 2-Aminoindane
- 2-FA
- 2-FEA
- 2-FMA
- 25B-NBOH
- 25C-NBOH
- 25C-NBOMe
- 25D-NBOMe
- 25I-NBOH
- 25I-NBOMe
- 25N-NBOMe
- 2C-B
- 2C-I
- 3,4-CTMP
- 3-Cl-PCP
- 3-FA
- 3-FEA
- 3-FMA
- 3-FPM
- 3-HO-PCE
- 3-HO-PCP
- 3-MMC
- 3-MeO-PCE
- 3-MeO-PCP
- 3C-E
- 3C-P
- 4-AcO-DET
- 4-FA
- 4-FMA
- 4F-EPH
- 4F-MPH
- 5-APB
- 5-Hydroxytryptophan
- 5-MAPB
- 6-APB
- 6-APDB
- A-PHP
- A-PVP
- AL-LAD
- ALD-52
- Acetylfentanyl
- Adrafinil
- Alcohol
- Amphetamine
Experience reports
Anecdotal reports which describe this effect within our experience index include:
- Experience: 22mg 2C-B (oral) / 100ug 1P-LSD (sublingual) - My first time tripping alone (2 days in a row)
- Experience: 300mg DXM (Oral) - Brink of the third
- Experience:1000 Morning Glory seeds - Rediscovering the Self
- Experience:1000 mg U47700 over 8 days - A harmful substance
- Experience:150μg tab 1P-LSD (oral) - Amazing and very long trip (20+ hours)
- Experience:1g Methiopropamine - Chasing the Chalky Dragon
- Experience:20mg Heroin - The Last Time I Shot Up
- Experience:3.5g psilocybe cubensis - Relinquishing of Material Chains/Fear and Desolation
- Experience:42 mg TMA-6: Pure Bliss
- Experience:70mg Lisdexamfetamine (oral) - My first stimulant experience
- Experience:A combination of DOC, 5-MAPB, 5-MeO-DMT, ETH-LAD, Cannabis, Pentedrone
- Experience:BK-2C-B - Various experiences
- Experience:FMA (37.5 mg, oral) - Never been this productive in my life
- Experience:Marijuana Withdrawal
- Experience:Mushrooms (~0.5 g) - Autonomous Voice
- Experience:~150mg MDA(oral) - a case of mistaken identity
See also
- Responsible use
- Subjective effects index
- Appetite enhancement
- Psychedelics - Subjective effects
- Dissociatives - Subjective effects
- Deliriants - Subjective effects
- Stimulants
- Psychedelics